Title |
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer
|
---|---|
Published in |
Clinical Drug Investigation, October 2019
|
DOI | 10.1007/s40261-019-00859-5 |
Pubmed ID | |
Authors |
Daniel Gallacher, Peter Auguste, Pamela Royle, Hema Mistry, Xavier Armoiry |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 21% |
Researcher | 3 | 13% |
Student > Ph. D. Student | 3 | 13% |
Student > Bachelor | 2 | 8% |
Librarian | 1 | 4% |
Other | 1 | 4% |
Unknown | 9 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 33% |
Computer Science | 2 | 8% |
Nursing and Health Professions | 2 | 8% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Economics, Econometrics and Finance | 1 | 4% |
Other | 1 | 4% |
Unknown | 9 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2020.
All research outputs
#20,582,908
of 23,166,665 outputs
Outputs from Clinical Drug Investigation
#889
of 983 outputs
Outputs of similar age
#297,770
of 350,302 outputs
Outputs of similar age from Clinical Drug Investigation
#11
of 15 outputs
Altmetric has tracked 23,166,665 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 983 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,302 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.